78 related articles for article (PubMed ID: 11890713)
1. A non-class I MHC intestinal epithelial surface glycoprotein, gp180, binds to CD8.
Campbell NA; Park MS; Toy LS; Yio XY; Devine L; Kavathas P; Mayer L
Clin Immunol; 2002 Mar; 102(3):267-74. PubMed ID: 11890713
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a 180-kDa intestinal epithelial cell membrane glycoprotein, gp180. A candidate molecule mediating t cell-epithelial cell interactions.
Yio XY; Mayer L
J Biol Chem; 1997 May; 272(19):12786-92. PubMed ID: 9139738
[TBL] [Abstract][Full Text] [Related]
3. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells.
Campbell NA; Kim HS; Blumberg RS; Mayer L
J Biol Chem; 1999 Sep; 274(37):26259-65. PubMed ID: 10473580
[TBL] [Abstract][Full Text] [Related]
4. Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.
Toy LS; Yio XY; Lin A; Honig S; Mayer L
J Clin Invest; 1997 Oct; 100(8):2062-71. PubMed ID: 9329971
[TBL] [Abstract][Full Text] [Related]
5. T cell responses modulated through interaction between CD8alphaalpha and the nonclassical MHC class I molecule, TL.
Leishman AJ; Naidenko OV; Attinger A; Koning F; Lena CJ; Xiong Y; Chang HC; Reinherz E; Kronenberg M; Cheroutre H
Science; 2001 Nov; 294(5548):1936-9. PubMed ID: 11729321
[TBL] [Abstract][Full Text] [Related]
6. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.
Stumptner C; Heid H; Fuchsbichler A; Hauser H; Mischinger HJ; Zatloukal K; Denk H
Am J Pathol; 1999 Jun; 154(6):1701-10. PubMed ID: 10362795
[TBL] [Abstract][Full Text] [Related]
7. Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis.
Roda G; Jianyu X; Park MS; DeMarte L; Hovhannisyan Z; Couri R; Stanners CP; Yeretssian G; Mayer L
Mucosal Immunol; 2014 May; 7(3):615-24. PubMed ID: 24104458
[TBL] [Abstract][Full Text] [Related]
8. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
10. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
[TBL] [Abstract][Full Text] [Related]
11. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
12. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.
Yao ZQ; Eisen-Vandervelde A; Waggoner SN; Cale EM; Hahn YS
J Virol; 2004 Jun; 78(12):6409-19. PubMed ID: 15163734
[TBL] [Abstract][Full Text] [Related]
13. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
Yu HX; Srinivasan N; Ren EE; Chan SH
Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
[TBL] [Abstract][Full Text] [Related]
14. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation.
Zhao MQ; Amir MK; Rice WR; Enelow RI
Am J Respir Cell Mol Biol; 2001 Sep; 25(3):362-9. PubMed ID: 11588015
[TBL] [Abstract][Full Text] [Related]
15. Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.
Cicinnati VR; Zhang X; Yu Z; Ferencik S; Schmitz KJ; Dworacki G; Kaczmarek E; Oldhafer K; Frilling A; Baba HA; Schmid KW; Grosse-Wilde H; Broelsch CE; DeLeo AB; Gerken G; Beckebaum S
Int J Cancer; 2006 Dec; 119(12):2851-60. PubMed ID: 16998881
[TBL] [Abstract][Full Text] [Related]
16. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
Shen SN; Xu Z; Qian XP; Ding YT; Yu LX; Liu BR
Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
[TBL] [Abstract][Full Text] [Related]
17. Human hepatoma cells expressing HLA class I molecules stimulate primary responses of purified CD8+ T lymphocytes.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Barnaba V
Res Virol; 1993; 144(4):327-32. PubMed ID: 8105523
[TBL] [Abstract][Full Text] [Related]
18. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
[TBL] [Abstract][Full Text] [Related]
19. Activation of a unique population of CD8(+) T cells by intestinal epithelial cells.
Allez M; Brimnes J; Shao L; Dotan I; Nakazawa A; Mayer L
Ann N Y Acad Sci; 2004 Dec; 1029():22-35. PubMed ID: 15681740
[TBL] [Abstract][Full Text] [Related]
20. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1.
Jiang H; Chess L
Annu Rev Immunol; 2000; 18():185-216. PubMed ID: 10837057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
